PMH4 COSTS AND CONSEQUENCES FOR METABOLIC SYNDROME, DIABETES AND CORONARY HEART DISEASE (CHD) RISK AMONG SCHIZOPHRENIA PATIENTS TREATED WITH ARIPIPRAZOLE VERSUS OLANZAPINE IN BRAZIL
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75471-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)75471-1/fulltext
Title :
PMH4 COSTS AND CONSEQUENCES FOR METABOLIC SYNDROME, DIABETES AND CORONARY HEART DISEASE (CHD) RISK AMONG SCHIZOPHRENIA PATIENTS TREATED WITH ARIPIPRAZOLE VERSUS OLANZAPINE IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75471-1&doi=10.1016/S1098-3015(10)75471-1
First page :
Section Title :
Open access? :
No
Section Order :
1396